Patricia Hurley
Patricia Hurley PhD is Vice President and head of regulatory affairs at F-star Therapeutics. She is responsible for overseeing the regulatory strategy for F-star’s innovative bispecific antibodies in immuno-oncology. A pharmacologist by training, Patricia spent several years in the global CRO and regulatory product development space.
EditorialA new era of digital and data-driven innovations
Such significant advances in information management and technology are providing us with sophisticated tools and new ways of working